1.            Ennetuse teadusnõukogu. Tervisesõnastik [kasutatud 23.07.2025]. Ennetuse sõnavara; 2022. https://tervisesonastik.tai.ee/tervisesonastik?keys=ennetuse%20teadusn%…

2.           Õunapuu L. Kvalitatiivne ja kvantitatiivne uurimisviis sotsiaalteadustes. Kärner E, toim. Tartu Ülikool; 2014. 

3.           Gottfredson DC, Cook TD, Gardner FEM jt. Standards of Evidence for Efficacy, Effectiveness, and Scale-up Research in Prevention Science: Next Generation. Prevention Science. 2015 Oct 29;16(7):893–926. 

4.          Streimann K, Pertel T, Vilms T jt. Ennetuse käsiraamat: sõltuvusainete tarvitamise ennetuse teaduslik käsitlus otsustajatele, arvamusliidritele ja poliitikakujundajatele. Kohandatud Euroopa ennetusõppekava (EMCDDA) põhjal. Tallinn: Tervise Arengu Instituut; 2020. 

5.           Edovald T, Firpo T, Roberts I. Running randomised controlled trials in innovation, entrepreneurship and growth. 2016 May. 

6.           Gupta K, Attri J, Singh A jt. Basic concepts for sample size calculation: Critical step for any clinical trials! Saudi J Anaesth. 2016;10(3):328. 

7.           Serdar CC, Cihan M, Yücel D jt. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb). 2021 Feb 15;31(1):27–53. 

8.           SPIRIT–CONSORT Group. SPIRIT-CONSORT website. [kasutatud 01.08.2025]. Extensions of the SPIRIT and CONSORT Statements. https://www.consort-spirit.org/extensions

9.           Hopewell S, Chan AW, Collins GS jt. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ. 2025 Apr 14;e081123. 

10.         Streimann K, Selart A, Trummal A. Effectiveness of a Universal, Classroom-Based Preventive Intervention (PAX GBG) in Estonia: a Cluster-Randomized Controlled Trial. Prevention Science. 2020 Feb 1;21(2):234–44. 

11.          Edovald T, Öeren M. Kontrollnimekiri juhuslikustatud kontrolluuringu läbiviimiseks SPIN-programmi mõju hindamisel. Tallinn; 2023. 

12.         Edovald T. Kontrafaktuaalne mõju hindamine: disainidest, rakendusvõimalustest ja väljakutsetest. 2023. 

13.         Leetmaa R, Võrk A, Eamets R jt. Aktiivse tööpoliitika tulemuslikkuse analüüs Eestis. Tallinn; 2003. 

14.         Guyatt GH, Oxman AD, Vist GE jt. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008 Apr 26;336(7650):924–6. 

15.         Laisaar KT. Kuidas tervist edendavaid, (tervise)probleeme ennetavaid sekkumisi hinnata? 2022. 

16.         Tael-Öeren M, Naughton F, Sutton S. A parent-oriented alcohol prevention program “Effekt” had no impact on adolescents’ alcohol use: Findings from a cluster-randomized controlled trial in Estonia. Drug Alcohol Depend. 2019 Jan 1;194:279–87. 

17.         Tartu Ülikool, Maailma Terviseorganisatsioon, Eesti Haigekassa. Eesti ravijuhendite koostamise käsiraamat [Internet]. 2011 [kasutatud 14.08.2024]. https://www.ravijuhend.ee/uploads/userfiles/ravijuhendi_kasiraamat_est…

18.         Chan AW, Boutron I, Hopewell S jt. SPIRIT 2025 statement: updated guideline for protocols of randomised trials. BMJ. 2025 Apr 28;389:e081477. 

19.         Hoffmann TC, Glasziou PP, Boutron I jt. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014 Mar 7;348(mar07 3):g1687–g1687. 

20.        Dobias ML. OSF. 2022 [kasutatud 31.07.2025]. AsPredicted Easy-Use Template & Tips for Pre-Registration Beginners. https://osf.io/byu28

21.         Streimann K, Trummal A, Klandorf K jt. Effectiveness of a universal classroom-based preventive intervention (PAX GBG): A research protocol for a matched-pair cluster-randomized controlled trial. Contemp Clin Trials Commun. 2017;8. 

22.         Drummond ME, Sculpher MJ, Torrance GW jt. Methods for the Economic Evaluation of Health Care Programmes. Oxford University PressOxford; 2005. 

23.         Tervisetehnoloogiate hindamise keskus. Tervisetehnoloogiate hindamise Eesti juhend [Internet]. Tartu; 2024 [kasutatud 7.10.2025]. https://dspace.ut.ee/server/api/core/bitstreams/87ab576b-ff41-43a9-aa33…

24.        Neumann PJ, Ganiats TG, Russell LB jt, toim. Cost-Effectiveness in Health and Medicine. Oxford University Press; 2016.

25.         Hale J. What contribution can health economics make to health promotion? Health Promot Int. 2000 Dec 1;15(4):341–8. 

26.        Mosadeghrad AM, Jaafaripooyan E, Zamandi M. Economic Evaluation of Health Interventions: A Critical Review. Iran J Public Health. 2022 Oct 24; 

27.        National Institute for Health and Care Excellence. NICE process and methods. 2022 [kasutatud 08.08.2025]. NICE health technology evaluations: the manual. https://www.nice.org.uk/process/pmg36/chapter/economic-evaluation-2

28.        Cox E, Walker S, Blower S jt. The cost-effectiveness of a proportionate parenting programme for primary caregivers and their child: an economic evaluation using evidence from the E-SEE Trial. BMC Health Serv Res. 2022 Dec 23;22(1):814. 

29.        Schweitzer J, Synowiec C. The Economics of eHealth and mHealth. J Health Commun. 2012 May 2;17(sup1):73–81. 

30.        Husereau D, Drummond M, Augustovski F jt. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMC Med. 2022 Dec 12;20(1):23. 

31.         Drummond M. F, Sculpher MJ, Claxton K jt. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford University Press; 2015. 

32.          Schepers J, Annemans L. The potential health and economic effects of plant-based food patterns in Belgium and the United Kingdom. Nutrition. 2018 Apr;48:24–32. 

Loe edasi →